Commentary: Pharmacy benefit managers, not Big Pharma, responsible for high drug prices

Flovent was pulled from shelves, but don't blame its maker: GSK chose to switch to a lower-priced generic. The pharmacy benefit managers made more money covering the more expensive version — and that's why they pulled it from the shelves, writes two experts.